Aldeyra Therapeutics Inc.

NASDAQ: ALDX · Real-Time Price · USD
5.58
0.14 (2.57%)
At close: Aug 19, 2025, 11:45 AM

Aldeyra Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
54.53M 142.82M 144.42M 229.79M
Short-Term Investments
46.62M n/a 29.88M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
2.48M n/a n/a -96.13K
Receivables
n/a n/a 3.24M 125M
Inventory
n/a n/a -3.24M -125M
Other Current Assets
301.15K 4.65M 6.29M 2.53M
Total Current Assets
101.86M 147.81M 181.02M 232.75M
Property-Plant & Equipment
266.95K 516.58K 268.54K 384.35K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.75M 516.58K 268.54K 384.35K
Total Assets
104.61M 148.33M 181.29M 233.14M
Account Payables
180.45K 1.34M 133.63K 1.02M
Deferred Revenue
6M n/a n/a n/a
Short-Term Debt
303K 15.15M 911.76K 229.61K
Other Current Liabilities
7.51M n/a 10.24M 8.78M
Total Current Liabilities
18.6M 22.26M 15.36M 11.77M
Long-Term Debt
15M 271.63K 14.92M 15.5M
Other Long-Term Liabilities
n/a -271.63K n/a n/a
Total Long-Term Liabilities
15M 6.27M 14.92M 15.63M
Total Liabilities
33.6M 28.53M 30.28M 27.4M
Total Debt
15.3M 15.66M 16.08M 15.86M
Common Stock
59.65K 59.2K 58.56K 58.08K
Retained Earnings
-450.11M -394.26M -356.72M -294.69M
Comprehensive Income
37.44K n/a -103.94K n/a
Shareholders Equity
71M 119.8M 151.01M 205.74M
Total Investments
46.62M n/a 29.88M n/a